September 18, 2018 | Letisia Marquez
Saul Priceman, Ph.D., an assistant research professor with City of Hope’s T Cell Immunotherapy Laboratory, is focused on developing more CAR T clinical trials for patients battling solid tumor cancers like breast and prostate cancer.
Ph.D. candidate leads groundbreaking study for neurodegenerative disease
October 17, 2018 | Maxine Nunes
Li Li's work, as a Ph.D. candidate at City of Hope, with Alexander disease may also shed new light on similar neurodegenerative conditions such as Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis.
Michael Caligiuri elected to National Academy of Medicine
October 15, 2018 | Letisia Marquez
Michael Caligiuri, M.D., has been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
Core Connection: Comprehensive Metabolic Phenotyping Core
October 4, 2018 | Katie Neith
As both genetics and environmental stimuli can have an effect on the progression of illnesses and on the efficacy of treatments, one particularly important area of study is metabolism, which lies at the intersection of many diseases.
New therapy shows promise for melanoma metastasized to the brain
October 1, 2018 | Maxine Nunes
Oncologist Kim Margolin, M.D., brings new hope to people with melanoma that has metastasized to the brain with a remarkable new study.
City of Hope scientist's stem cell model could be key to slowing Alzheimer's
September 28, 2018 | Zen Vuong
Treatments for a rare nervous system disorder and, eventually, Alzheimer's disease could be influenced by new research conducted by City of Hope's Yanhong Shi, Ph.D.
CIRM Awards City of Hope Researchers $3.7 million to Develop Glioblastoma Clinical Trial
September 28, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.